文献速递头颈神经PETMR

头颈部混合生长抑素受体PET/MRI

Hybrid Somatostatin Receptor PET/MRI of the Head and Neck.
PubMed 文献 · Radiographics · 2024-01-01

本文讨论生长抑素受体PET/MRI在头颈部表达生长抑素受体肿瘤中的应用,包括脑膜瘤、副神经节瘤、嗅神经母细胞瘤、垂体神经内分泌肿瘤、中耳神经内分泌肿瘤和甲状腺髓样癌。作者指出,PET与MRI结合优于任一单独模态,可改善病灶定位、更敏感显示病变范围、增强监测、优化放疗计划并准确预测对生长抑素类似物治疗的反应。

要点

  • 生长抑素受体PET/MRI适用于头颈部表达生长抑素受体的肿瘤,如脑膜瘤、副神经节瘤等。
  • PET与MRI结合优于任一单独模态,可克服PET单独定位困难。
  • 该技术可改善病灶定位、更敏感显示病变范围、增强监测、优化放疗计划并预测治疗反应。

核心结论

  • 生长抑素受体PET/MRI在头颈部表达生长抑素受体肿瘤的评估中具有优势,放射科医生应了解其优势及潜在陷阱以准确建议临床并更好解读检查。

研究设计与样本

  • 本文为综述,讨论混合生长抑素受体PET/MRI在头颈部肿瘤中的应用,未报告系统检索范围与纳入文献数量。

临床应用与阅片要点

  • 作者指出放射科医生应了解生长抑素受体PET/MRI在头颈部肿瘤评估中的优势及潜在陷阱,以便准确建议临床医生并更好地解读这些检查。

局限性

  • 原文指出临床实践中专用的PET/MRI设备仅有少数可用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Hybrid PET/MRI has the potential to transform neuro-oncologic imaging, particularly in diagnosis and treatment planning of somatostatin receptor-expressing tumors of the head and neck. Hybrid PET/MRI combines high-resolution MRI with functional information from PET, providing precise anatomic information and overcoming difficulties in localization inherent to PET alone. There is a range of tumors in the head and neck that overexpress somatostatin receptors and are therefore amenable to evaluation with somatostatin receptor PET/MRI. These include meningiomas, paragangliomas, olfactory neuroblastomas, pituitary neuroendocrine tumors, middle ear neuroendocrine tumors, and medullary thyroid carcinomas. The combination of PET and MRI is superior to either modality alone and can address several unique diagnostic challenges associated with these lesions. The authors discuss the superior capabilities of somatostatin receptor PET/MRI, including improved lesion localization, more sensitive demonstration of disease extent, enhanced surveillance, optimized radiation therapy planning, and accurate prediction of response to somatostatin analog therapy. Although there are only a few dedicated PET/MRI units available in clinical practice, commercial software is now available that can automatically fuse PET/CT data with recently acquired MRI data, increasing the availability of this approach. Radiologists should be aware of the advantages of somatostatin receptor PET/MRI in evaluation of head and neck tumors as well as the potential pitfalls of this approach so that they can accurately advise clinicians and better interpret these studies. ©RSNA, 2024 See the invited commentary by Shatzkes and Strauss in this issue.

来源:Radiographics,查看原文。版权归原作者所有。

引用

  1. Keir G, Petrover D, Caravella C, et al. Hybrid Somatostatin Receptor PET/MRI of the Head and Neck. Radiographics. 2024. PMID: 39325659. doi:10.1148/rg.240020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。